UroGen Pharma (URGN) EBIT (2017 - 2026)
UroGen Pharma's EBIT came in at $111,000 for Q2 2026, compared with -$41.45 million a year earlier.
Powered by 
Analysis
UroGen Pharma (URGN) EBIT (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, UroGen Pharma reported EBIT of -$66.65 million; for FY2025, it came in at -$124.86 million.
- Going back by year, EBIT was -$96.78 million in FY2024, -$65.54 million in FY2023, -$79.04 million in FY2022 and -$92.29 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBIT in data going back to Q1 2017.
- Business Quant data shows URGN's EBIT at -$20.26 million (Q1 2026), -$19.12 million (Q4 2025) and -$27.39 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | UroGen Pharma | 1.99 Bn | 1.49 Bn | 65.88 Mn | 111,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111,000.00 |
| Mar 31, 2026 | -20.26 Mn |
| Dec 31, 2025 | -19.12 Mn |
| Sep 30, 2025 | -27.39 Mn |
| Jun 30, 2025 | -41.45 Mn |
| Mar 31, 2025 | -36.91 Mn |
| Dec 31, 2024 | -27.66 Mn |
| Sep 30, 2024 | -17.55 Mn |
| Jun 30, 2024 | -25.84 Mn |
| Mar 31, 2024 | -25.74 Mn |
| Dec 31, 2023 | -14.61 Mn |
| Sep 30, 2023 | -13.50 Mn |
| Jun 30, 2023 | -15.38 Mn |
| Mar 31, 2023 | -22.05 Mn |
| Dec 31, 2022 | -20.28 Mn |
| Sep 30, 2022 | -18.09 Mn |
| Jun 30, 2022 | -18.72 Mn |
| Mar 31, 2022 | -21.96 Mn |
| Dec 31, 2021 | -19.92 Mn |
| Sep 30, 2021 | -23.44 Mn |
API Access
UroGen Pharma EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();